Releases Geral
Nikkiso Expands Operations in the U.S. to Support Its Growing Hydrogen Business
AGÊNCIA DE COMUNICAÇÃO Conteúdo de responsabilidade da empresa 5 de outubro de 2023
Cryogenic Industries
TEMECULA, Calif., Oct. 05, 2023 (GLOBE NEWSWIRE) — Nikkiso Clean Energy & Industrial Gases Group (Group), part of Nikkiso Co., Ltd., announced today that it has acquired full ownership of its facility in Murrieta, Calif., and 16.4 acres of land to expand its manufacturing and testing operations.
Currently the Group builds and tests cryogenic vaporizers, heat exchangers, process skids, air separation units, and liquefaction products the expansion will add four hydrogen testing stations on site to support the Groups growing hydrogen business.
The hydrogen economy is accelerating as the energy transition progresses, and Nikkiso has a large role to play, said Peter Wagner, CEO, Nikkiso Clean Energy & Industrial Gases. This facility expansion allows us to scale operations and better support global demand for our state-of-the-art cryogenic products and technologies.
Construction will begin in the first half of 2024.
About Nikkiso Clean Energy & Industrial Gases
Nikkiso Clean Energy & Industrial Gases Group is part of the Industrial Division of Nikkiso Co., Ltd. in Japan. The Group is headquartered in Southern California with facilities, offices, and service centers around the world to manufacture and service engineered cryogenic gas processing equipment (pumps, turboexpanders, heat exchangers, etc.), and process plants for industrial gases, natural gas liquefaction (LNG), hydrogen liquefaction, ammonia, and carbon capture and liquefaction.
Media contact
Lisa Adams
+1 405 492 1689
A OESP nao e(sao) responsavel(is) por erros, incorrecoes, atrasos ou quaisquer decisoes tomadas por seus clientes com base nos Conteudos ora disponibilizados, bem como tais Conteudos nao representam a opiniao da OESP e sao de inteira responsabilidade da GlobeNewswire
Leia também
-
Releases Geral Boehringer Ingelheim shares positive results from the first study worldwide in diabetic macular ischemia
6 de maio de 2024Boehringer Ingelheim today presented positive data from the HORNBILL Phase I/IIa study of BI 764524, the first ever study exploring a potential treatment for people
Saiba Mais -
Releases Geral Laser&Co projeta abertura de mais 100 unidades para este ano
18 de janeiro de 2024DINO DIVULGADOR DE NOTÍCIAS São Paulo – SP–(DINO – 18 jan, 2024) – A Lase&Co, rede de clínicas especializada em serviços estéticos a laser, com 40
Saiba Mais -
Releases Geral Mavenir e Whitestack Expandem Ecossistema de Funções de Rede Aberta
27 de agosto de 2024RICHARDSON, Texas, Aug. 27, 2024 (GLOBE NEWSWIRE) -- A Mavenir, fornecedora de infraestrutura de rede nativa na nuvem que estabelece o futuro das redes, e a Whitestack, d
Saiba Mais